SCHEMBL3129590

SCHEMBL3129590

O=C(O)c1cccc(N(Cc2ccccc2F)c2ccc(OC(F)F)c(OC(F)F)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.43
PDE4D Q08499 3/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
MRGPRX4 Q96LA9 3/20 0.40
AKR1C3 P42330 1/20 0.38
LPAR1 Q92633 2/20 0.38
LPAR5 Q9H1C0 2/20 0.38
PPARA Q07869 2/20 0.38
TAS2R14 Q9NYV8 2/20 0.36
PTGER1 P34995 1/20 0.36
HCAR3 P49019 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
POLB P06746 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3121009 0.89 PDE4A (0.42) PDE4APDE4DPDE4BPDE4CMRGPRX4
SCHEMBL3203452 0.86 PDE4A (0.37) PDE4APDE4DPDE4BPDE4CMEN1
SCHEMBL3128395 0.84 PPARA (0.50) PDE4APDE4DPDE4BPDE4CMRGPRX4
SCHEMBL3129663 0.83 HTT (0.41) PDE4APDE4DPDE4BPDE4CMRGPRX4
SCHEMBL3131270 0.83 PDE4A (0.46) PDE4APDE4DPDE4BPDE4CMRGPRX4
SCHEMBL2908126 0.83 MRGPRX4 (0.42) PDE4APDE4DPDE4BPDE4CMRGPRX4
SCHEMBL3129460 0.80 PDE4A (0.42) PDE4APDE4DPDE4BPDE4CMRGPRX4
SCHEMBL3126102 0.79 PDE4D (0.39) PDE4APDE4DPDE4BPDE4CMRGPRX4
SCHEMBL1159028 0.78 GRM2 (0.44) PDE4APDE4DPDE4BPDE4CMRGPRX4
SCHEMBL2908726 0.78 MRGPRX4 (0.44) PDE4APDE4DPDE4BPDE4CMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US claimed
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
WO-2010003084-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B PDE4A 1/4885PDE4D 9/4885PDE4B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.